Dose intensity and outcome with combination chemotherapy for germ cell carcinoma
- 1 July 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (7) , 1073-1077
- https://doi.org/10.1016/0277-5379(89)90391-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.Journal of Clinical Oncology, 1988
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group studyCancer, 1984
- A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.Journal of Clinical Oncology, 1983
- The Role of Surgery Following Chemotherapy in Stage III Germ Cell NeoplasmsJournal of Urology, 1982
- Surgical resection of residual tumor after chemotherapy in non-seminomatous testicular cancerEuropean Journal of Cancer and Clinical Oncology, 1982
- Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreductionCancer, 1981
- Combined chemotherapy and surgery in treatment of advanced germ-cell tumorsCancer, 1981
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958